Human immunodeficiency virus (HIV) and Epstein-Barr virus (EBV) Related Lymphomas, pathology view point
The contribution of Epstein Barr virus (EBV) and Kaposi sarcoma herpes virus (KSHV) to the development of specific types of malignant lymphomas occurring in the human immunodeficiency virus (HIV) setting has been extensively studied since the beginning of the HIV epidemic 35 years ago. The introduction of highly active antiretroviral therapies (HAART) in 1996 has changed dramatically the incidence of HIV-related malignancies. Nevertheless, malignant lymphomas continue to be the major group of malignances observed in HIV infected individuals, and the most common cause of cancer related-deaths.
Source: Seminars in Diagnostic Pathology - Category: Pathology Authors: Ebru Linke-Serins öz, Falko Fend, Leticia Quintanilla-Martinez Source Type: research
More News: Cancer | Cancer & Oncology | Epidemics | Epidemiology | Herpes | Highly Active Antiretroviral Therapy | Lymphoma | Pathology | Sarcomas